Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia

Neuropsychopharmacology. 2000 Aug;23(2):170-7. doi: 10.1016/S0893-133X(99)00156-6.

Abstract

There has been increasing evidence that deranged superoxide dismutase (SOD) activities might be a risk factor for schizophrenia and/or tardive dyskinesia (TD). In the present study, we investigated the genetic association between a functional polymorphism (Ala-9Val) in the human manganese (Mn) SOD gene and schizophrenia or TD (192 schizophrenics: 39 with TD and 153 without TD; 141 controls). No significant differences in the allelic or genotypic distribution between schizophrenics and controls were observed. However, we did find a significant difference in genotypic distribution between schizophrenics with and those without TD (p =. 03). Moreover, decreased -9Ala (mutant) allele was found among patients with TD (p =.02; odds ratio = 0.29; 95% confidence interval = 0.10-0.83). In conjunction with previous findings of increased free radicals and decreased SOD activities in TD subjects, these results suggest that the -9Ala (high activity) MnSOD allele may play a role in protecting against susceptibility to TD in schizophrenics.

MeSH terms

  • Age Distribution
  • Alleles
  • Case-Control Studies
  • Comorbidity
  • Dyskinesia, Drug-Induced / epidemiology
  • Dyskinesia, Drug-Induced / genetics*
  • Female
  • Gene Frequency
  • Humans
  • Japan / epidemiology
  • Logistic Models
  • Male
  • Middle Aged
  • Models, Statistical
  • Odds Ratio
  • Polymorphism, Genetic*
  • Schizophrenia / enzymology
  • Schizophrenia / epidemiology
  • Schizophrenia / genetics*
  • Sensitivity and Specificity
  • Sex Distribution
  • Superoxide Dismutase / genetics*

Substances

  • Superoxide Dismutase